StopAfib.org is seeking afib patients interested in participating in an advocacy training program.
The training program will help prepare individuals to share patient perspectives with various audiences and participate in advocacy activities.
The training will take place virtually and consist of two half-day sessions, January 19-20, 2023.
Following that, if you would like to refine your personal patient story, two small group sessions will be offered on January 27 and February 10.
If you are interested in learning more or wish to apply, see:
I have afib.. was put on medicine called eliquist.. after having a stroke. About a year later several months ago, I had a severe heart attack.. and continued.. to take, eliquis plus metoprolol SUCC ER 25 MG TABLET TWICE A DAY.. ONE IN THE MORNING ONE AT NIGHT. I HAVE BEEN ON ELIQUIST ALMOST 2 YEARS AND NEVER HAD A COAGULATIONTEST? IS THAT BAD.. AND OTHER LIFE-THREATEN BC.. I’M IN MORE PAIN, have gained weight AND I FEEL TIRED ALL THE TIME. Can this cause weight gain and extreme fatigue?? Thank you in advance.
Hi, Lorena,
Thank you for sharing your afib story about your experience with Elliquis. You may be interested in joining our patient discussion forum (http://forum.stopafib.org/index.php) to connect with other patients who collectively have a great amount of knowledge and experience. You may want to post your story and questions there, and you may also learn a lot from others who have already shared their experience.
You’ll need to join to see and participate in the discussion. To do so, go to forum.stopafib.org, and click on the big red button that says, “Sign Up”. Once you sign up by registering your email address, your preferred username, and a password, you’ll receive an email to confirm your interest in joining the forum. Click on the confirmation link in that email, and you are ready to go. You’ll be able to log into the forum, read the discussions, and participate. I hope that you are able to find others to connect with there that can give you advice, suggestions, and hope.